Form D · Pharmaceuticals
ONCOQUEST PHARMA USA, INC
Miryang Si, Gyeongsangnamdo, M5 · CIK 0001839861
Offering snapshot reported May 11, 2021 · SEC filing
- Reported sold
- $360K Offering amount: $360K
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 11, 2021 | Initial | $360,000 | No comparison | Not reported | SEC filing |
| Jan 13, 2021 | Initial | $510,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-398916
Source: Form D, filed May 11, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Alex Jung | Director, Executive |
| Lyn Lim | Director |
| Ragupathy Madiyalakan | Director, Executive |
| Karthik Radhakrishnan | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
670 21, Sannae Ro, Sannae Myeon
Miryang Si, Gyeongsangnamdo, M5, 50414
Miryang Si, Gyeongsangnamdo, M5, 50414